Growth Metrics

Vertex Pharmaceuticals (VRTX) FCF Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 10,029.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 723.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,409.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,066.00
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 723.00
Dec 31, 2025 -3,444.00
Sep 30, 2025 -157.00
Jun 30, 2025 -1,819.00
Mar 31, 2025 -1,446.00
Dec 31, 2024 -2,813.00
Sep 30, 2024 288.00
Jun 30, 2024 -13,057.00
Mar 31, 2024 -328.00
Dec 31, 2023 -2,026.00
Sep 30, 2023 179.00
Jun 30, 2023 -2,384.00
Mar 31, 2023 -1,643.00
Dec 31, 2022 -23,015.00
Sep 30, 2022 592.00
Jun 30, 2022 194.00
Mar 31, 2022 682.00
Dec 31, 2021 1,067.00
Sep 30, 2021 -185.00
Jun 30, 2021 -5,275.00
Mar 31, 2021 1,444.00
Dec 31, 2020 -105.00
Sep 30, 2020 2,307.00
Jun 30, 2020 3,676.00
Mar 31, 2020 1,693.00
Dec 31, 2019 24,720.00
Sep 30, 2019 2,005.00
Jun 30, 2019 4,167.00
Mar 31, 2019 4,254.00
Dec 31, 2018 3,027.00
Sep 30, 2018 6,937.00
Jun 30, 2018 11,331.00
Mar 31, 2018 21,273.00
Dec 31, 2017 16,422.00
Sep 30, 2017 9,529.00
Jun 30, 2017 14,434.00
Mar 31, 2017 19,711.00
Dec 31, 2016 2,422.00
Sep 30, 2016 2,718.00
Jun 30, 2016 693.00
Mar 31, 2016 1,828.00
Dec 31, 2015 34.00
Sep 30, 2015 -4,859.00
Jun 30, 2015 -9,907.00
Mar 31, 2015 -17,701.00
Dec 31, 2014 -22,366.00
Sep 30, 2014 -7,855.00
Mar 31, 2014 9,845.00
Dec 31, 2013 27,962.00
Sep 30, 2013 72,015.00
Jun 30, 2013 37,390.00
Mar 31, 2013 86,471.00
Dec 31, 2012 32,806.00
Sep 30, 2012 13,090.00
Jun 30, 2012 66,795.00
Mar 31, 2012 80,041.00